다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Kyverna Therapeutics Inc (KYTX)
Kyverna Therapeutics Inc (KYTX) 뉴스

KYTX

Kyverna Therapeutics (KYTX)

Kyverna Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KYTX

1

일자	시간	출처	헤드라인	심볼	기업
2024/06/14	19:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/06/11	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/06/11	05:05	PR Newswire (US)	Kyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews Immunology	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/06/08	05:06	PR Newswire (US)	Kyverna Therapeutics to Present Data on 50 Patient Experience at Symposium at EULAR 2024	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/05/30	05:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/05/15	05:29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/05/15	05:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/05/15	05:05	PR Newswire (US)	Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/04/12	06:01	PR Newswire (US)	Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune Diseases	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/03/30	03:59	PR Newswire (US)	First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in Med	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/03/27	05:05	PR Newswire (US)	Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/03/08	09:26	PR Newswire (US)	Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis	NASDAQ:KYTX	Kyverna Therapeutics Inc
2024/02/13	06:39	PR Newswire (US)	Kyverna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares	NASDAQ:KYTX	Kyverna Therapeutics Inc

검색 관련기사 보기:NASDAQ:KYTX

1

Bank of America

Invesco QQQ Trust Series 1

Health Care Select Sector

US Dollar vs Yen

Verizon Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관